Europe — EMA
Olanzapine Eg
Olanzapine, the active ingredient in Olanzapine Eg, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapine Eg, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents.
GNH USA supplies Olanzapine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine Eg is an atypical antipsychotic that modulates neurotransmission in several psychiatric disorders. - Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Bipolar I disorder (manic episodes): Controls acute mania and maintains mood stability. - Schizoaffective disorder: Alleviates psychotic features and mood disturbances.
What are the side effects of Olanzapine?
Olanzapine may cause a range of adverse reactions that vary in frequency and severity.
Common Side Effects: - Weight gain: Increased appetite and caloric intake. - Sedation: Drowsiness or feeling of being slowed down. - Dry mouth: Reduced salivation. - Constipation: Decreased bowel motility. - Elevated triglycerides: Changes in lipid metabolism. - Orthostatic hypotension: Light‑headedness on standing.
Serious or Rare Side Effects: - Neuroleptic malignant syndrome: Potentially life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: Involuntary, repetitive movements. - Hyperglycaemia: Significant rise in blood glucose levels. - Seizures: Increased risk of convulsive episodes. - Agranulocytosis: Marked reduction in white‑blood cell count. - Severe allergic reactions: Anaphylaxis or skin rash.
What precautions apply to Olanzapine?
When prescribing Olanzapine Eg, clinicians should consider several safety aspects. - Metabolic monitoring: Regularly check weight, glucose, and lipid profiles. - Cardiovascular assessment: Monitor blood pressure and heart rate, especially at treatment start. - CNS depression: Caution when combined with other sedatives or alcohol. - Pregnancy and lactation: Evaluate risk‑benefit ratio before use. - Elderly patients with dementia-related psychosis: Increased risk of mortality. - Store below 25°C: keep in the original pack, protect from moisture.
What does Olanzapine interact with?
Olanzine Eg can interact with a variety of medicines, altering efficacy or safety.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors: Reduce olanzapine clearance; may increase toxicity. - Benzodiazepines: Additive CNS depression. - Antihistamines: Heightened sedative effect.
Moderate Interactions (Monitor Closely): - CYP2D6 substrates: May require dose adjustment. - Antihypertensive agents : May enhance hypotensive effects. - Smoking : Induces CYP1 and CYP2 enzymes ".
